188 related articles for article (PubMed ID: 8672709)
1. Design considerations in crossover trials with a single interim analysis and serial patient entry.
Cook RJ; Willan AR
Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709
[TBL] [Abstract][Full Text] [Related]
2. Interim analyses in 2 x 2 crossover trials.
Cook RJ
Biometrics; 1995 Sep; 51(3):932-45. PubMed ID: 7548709
[TBL] [Abstract][Full Text] [Related]
3. Use of two-stage test statistic in the two-period crossover trials.
Wang SJ; Hung HM
Biometrics; 1997 Sep; 53(3):1081-91. PubMed ID: 9333341
[TBL] [Abstract][Full Text] [Related]
4. A comment on interim analyses in crossover trials.
Grieve AP; Senn S
Biometrics; 1996 Dec; 52(4):1515-20. PubMed ID: 9019232
[TBL] [Abstract][Full Text] [Related]
5. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
6. Increasing the sample size when the unblinded interim result is promising.
Chen YH; DeMets DL; Lan KK
Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
[TBL] [Abstract][Full Text] [Related]
7. A group-sequential design for clinical trials with treatment selection.
Stallard N; Friede T
Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
[TBL] [Abstract][Full Text] [Related]
8. Bayesian design and analysis of two x two factorial clinical trials.
Simon R; Freedman LS
Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445
[TBL] [Abstract][Full Text] [Related]
9. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
10. Tests for the analysis of variance of crossover designs with correlated errors.
Bellavance F; Tardif S; Stephens MA
Biometrics; 1996 Jun; 52(2):607-12. PubMed ID: 8672705
[TBL] [Abstract][Full Text] [Related]
11. Interim analysis on survival data: its potential bias and how to repair it.
van Houwelingen HC; van de Velde CJ; Stijnen T
Stat Med; 2005 Sep; 24(18):2823-35. PubMed ID: 16025546
[TBL] [Abstract][Full Text] [Related]
12. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.
Jennison C; Turnbull BW
Biometrics; 1993 Sep; 49(3):741-52. PubMed ID: 8241370
[TBL] [Abstract][Full Text] [Related]
13. A multiple-step selection procedure with sequential protection of preferred treatments.
Chen TT; Simon R
Biometrics; 1993 Sep; 49(3):753-61. PubMed ID: 8241371
[TBL] [Abstract][Full Text] [Related]
14. Carryover and the two-period crossover clinical trial.
Willan AR; Pater JL
Biometrics; 1986 Sep; 42(3):593-9. PubMed ID: 3567292
[TBL] [Abstract][Full Text] [Related]
15. Implementation of group sequential logrank tests in a maximum duration trial.
Lan KK; Lachin JM
Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
[TBL] [Abstract][Full Text] [Related]
16. A comparison of two methods for adaptive interim analyses in clinical trials.
Wassmer G
Biometrics; 1998 Jun; 54(2):696-705. PubMed ID: 9629649
[TBL] [Abstract][Full Text] [Related]
17. Interim monitoring of longitudinal comparative studies with recurrent event responses.
Cook RJ; Lawless JF
Biometrics; 1996 Dec; 52(4):1311-23. PubMed ID: 8962455
[TBL] [Abstract][Full Text] [Related]
18. Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statistic.
Chang MN; Shuster JJ
Biometrics; 1994 Sep; 50(3):827-33. PubMed ID: 7981402
[TBL] [Abstract][Full Text] [Related]
19. Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC
Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
[TBL] [Abstract][Full Text] [Related]
20. Using the maximum test statistic in the two-period crossover clinical trial.
Willan AR
Biometrics; 1988 Mar; 44(1):211-8. PubMed ID: 3358989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
